At a glance
ClinicalIndex Comparison RecordN/ACompleted· 245 enrolled
Drug / intervention
Observational Studies: participants treated according to the real clinical practice.other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Assessment of the Social Cost of Crohn's Disease (COsto Sociale Della Malattia di CrOhn - COSMO): Economic and Quality of Life Aspects
In Brief
An observational study evaluating Observational Studies: participants treated according to the real clinical practice. for Inflammatory Bowel Disease and Crohn's Disease. Completed, enrolled 245 participants.
Detailed Summary
This observational study will evaluate the social cost and quality of life of participants who have had Crohn's Disease for at least 6 months and have active disease despite drug therapy. Participants are followed for a total of 18 months.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsInflammatory Bowel Disease, Crohn's Disease
Countries--
Collaborators--
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 2006
First PostedJul 2008
Primary CompletionDec 2009
TodayJul 2026
First PostedJul 29, 2008
Enrollment StartSep 1, 2006
Primary CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 17.9 years ago
Interventions
Observational Studies: participants treated according to the real clinical practice.other
No intervention was administered to the participants specifically for the purpose this study. Participant could be on any drug therapy.